Product NDC: | 0173-0753 |
Proprietary Name: | VERAMYST |
Non Proprietary Name: | fluticasone furoate |
Active Ingredient(s): | 27.5 ug/1 & nbsp; fluticasone furoate |
Administration Route(s): | NASAL |
Dosage Form(s): | SPRAY, METERED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0753 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022051 |
Marketing Category: | NDA |
Start Marketing Date: | 20070515 |
Package NDC: | 0173-0753-60 |
Package Description: | 30 SPRAY, METERED in 1 BOTTLE, PUMP (0173-0753-60) |
NDC Code | 0173-0753-60 |
Proprietary Name | VERAMYST |
Package Description | 30 SPRAY, METERED in 1 BOTTLE, PUMP (0173-0753-60) |
Product NDC | 0173-0753 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | fluticasone furoate |
Dosage Form Name | SPRAY, METERED |
Route Name | NASAL |
Start Marketing Date | 20070515 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | FLUTICASONE FUROATE |
Strength Number | 27.5 |
Strength Unit | ug/1 |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |